Thromb Haemost 1997; 78(02): 902-909
DOI: 10.1055/s-0038-1657650
Rapid Communication
Schattauer GmbH Stuttgart

Effect of a New Monoclonal Anti-Glycoprotein IX Antibody, KMP-9, on High Shear-Induced Platelet Aggregation[*]

Tetsuya Miyake
1   The First Department of Internal Medicine, Kansai Medical University, Osaka, Japan
,
Shosaku Nomura
1   The First Department of Internal Medicine, Kansai Medical University, Osaka, Japan
,
Yutaka Komiyama
2   Department of Clinical Sciences and Laboratory Medicine, Kansai Medical University, Osaka, Japan
,
Yasuhiko Miyazaki
1   The First Department of Internal Medicine, Kansai Medical University, Osaka, Japan
,
Hideo Kagawa
1   The First Department of Internal Medicine, Kansai Medical University, Osaka, Japan
,
Midori Masuda
2   Department of Clinical Sciences and Laboratory Medicine, Kansai Medical University, Osaka, Japan
,
Hakuo Takahashi
2   Department of Clinical Sciences and Laboratory Medicine, Kansai Medical University, Osaka, Japan
,
Yoshihiro Fujimura
3   Department of Blood Transfusion, Nara Medical College, Nara, Japan
,
Yasuo Ikeda
4   Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
,
Shirou Fukuhara
1   The First Department of Internal Medicine, Kansai Medical University, Osaka, Japan
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 09. 1996

Accepted after revision 03. April 1997

Publikationsdatum:
12. Juli 2018 (online)

Summary

Human platelet glycoprotein Ib/IX complex acts as a receptor for von Willebrand factor. It is widely accepted that glycoprotein lb is the essential receptor component, but the role of glycoprotein IX is still unclear. We produced a new monoclonal anti-glycoprotein IX antibody (KMP-9) by the hybridoma technique using platelets from a patient with Glanzmann’s thrombasthenia. The epitope of KMP-9 was localized to the C-terminal 8 kD fragment of glycoprotein IX using ELISA analysis of polyethylene-pin-synthesized peptides, as well as Western blot analysis of platelets after digestion with N-glycosidase and Staphylococcus aureus V8 protease. KMP-9 partially inhibited high shear stress-induced platelet aggregation, but had no effect on aggregation induced by ristocetin or low shear stress. Its inhibitory effect on high shear stress-induced aggregation was weaker than that of antiglycoprotein lb or anti-glycoprotein Ilb/IIIa monoclonal antibodies. A 21-mer synthetic peptide (glycoprotein IX L110-G130) inhibited the binding of KMP-9 to platelets. It also competively inhibited the suppression of high shear stress-induced platelet aggregation by KMP-9, but had no direct effect on this aggregation. KMP-9 may be useful to clarify the physiological role of GPIX.

This work was partly supported by a Research Grant for Advanced Medical Care from the Ministry of Health and Welfare of Japan


 
  • References

  • 1 Clemetson KJ, McGregor JL, James E, Dechavanne M, Luscher EF. Characterization of the platelet membrane glycoprotein abnormalities in Bemard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest 1982; 70: 304-311
  • 2 Du X, Beutler L, Ruan C, Castaldi PA, Bemdt MC. Glycoprotein lb and glycoprotein IX are fully complexed in the intact platelet membrane. Blood 1987; 69: 1524-1527
  • 3 Berndt MC, Gregory C, Kabral A, Zola H, Fournier D, Castaldi PA. Purification and preliminary characterization of the GP lb complex in the human platelet membrane. Eur J Biochem 1985; 151: 637-649
  • 4 Sakariassen KS, Nievelstein PFEM, Coller BS, Sixma JJ. Role of platelet membrane glycoprotein lb and Ilb/IIIa in platelet adhesion to human artery subendothelium. Br J Haematol 1986; 63: 681-691
  • 5 Vicente V, Houghten RA, Ruggeri ZM. Identification of a site in the a chain of platelet glycoprotein lb that participates in von Willebrand factor binding. J Biol Chem 1990; 265: 274-280
  • 6 Roth GJ. Developing relationship: Arterial platelet adhesion, glycoproteinlb and leucine-rich glycoproteins. Blood 1991; 77: 05-19
  • 7 Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, Anbo H, Kawai Y, Watanabe K, Itagaki I, Sakai K, Ruggeri ZM. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 1991; 87: 1234-1240
  • 8 Ikeda Y, Handa M, Kamata T, Kawana K, Kawai Y, Watanabe K, Kawakami K, Sakai K, Fukuyama M, Itagaki I, Yoshioka A, Ruggeri ZM. Transmembrane calcium influx associated with von Willebrand factor binding to GPIb in the initiation of shear-induced platelet aggregation. Thromb Haemost 1993; 69: 496-502
  • 9 Ruggeri ZM. Mechanisms of shear-induced platelet aggregation. Thromb Haemost 1993; 70: 119-123
  • 10 Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Heliums JD. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress- induced platelet aggregation. J Clin Invest 1986; 78: 1456-1461
  • 11 Moake JL, Turner NA, Stathopoulos NA, Nolasco HLH, Heliums JD. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 1988; 58: 1366-1374
  • 12 Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-297
  • 13 O’Brien JR. Shear-induced platelet aggregation. Lancet 1990; 335: 711-713
  • 14 Wright SD, Michaelides K, Johnson DJD, West NC, Tuddenham EGD. Double heterozygosity for mutations in the platelet glycoprotein IX gene in three siblings with Bemard-Soulier syndrome. Blood 1993; 81: 2339-2347
  • 15 Drouin J, McGregor JL, Parmentier S, Izaguirre CA, Clemetson KJ. Residual amounts of glycoprotein lb concomitant with near absence of glycoprotein IX in platelets of Bemard-Soulier patients. Blood 1988; 72: 1086-1088
  • 16 Berndt MC, Gregory C, Chong BH, Zora H, Castaldi PA. Additional glycoprotein defects in Bemard-Soulier syndrome: Confirmation of genetic basis by parental analysis. Blood 1983; 62: 800-807
  • 17 Lopez JA, Leung B, Reynolds CC, Li CQ, Fox JEB. Efficient plasma membrane expression of a functional platelet glycoprotein Ib-IX complex requires the presence of its three subunits. J Biol Chem 1992; 267: 12851-12859
  • 18 Nurden AT, Caen JP. An abnormal platelet glycoprotein pattern in three cases of Glanzmann’s thrombasthenia. Br J Haematol 1974; 28: 253-260
  • 19 Fujimura Y, Titani K, Holland LZ, Russel SR, Roberts JR, Elder JH, Ruggeri ZM, Zimmerman TS. von Willebrand factor: A reduced and alkylated 52/48 kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein lb. J Biol Chem 1986; 261: 381-385
  • 20 Fujimura Y, Titani K, Usami Y, Suzuki M, Oyama R, Matsui T, Fukui H, Sugimoto M, Ruggeri ZM. Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca. Biochemistry 1991; 30: 1957-1964
  • 21 Coller BS, Peerschke El, Scudder LE, Sulliran CA. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoprotein IIb and/or IIIa. J Clin Invest 1983; 72: 325-328
  • 22 Clamp JR, Hughes KW, Mcpherson JC. Enzyme-linked immunosorbent assay (ELISA): quantitative assay of immunoglobulin G. Immunochemistry 1971; 08: 871-879
  • 23 Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1976; 76: 4350-4354
  • 24 Lamoyi E. Preparation of F(ab’)2fragments from mouse IgG of various subclass. Methods in Enzymology 1986; 121: 652-663
  • 25 Berndt MC, Chong BH, Bull HA, Zola H, Castaldi PA. Molecular characterization of quinine/quinidine drug-dependent antibody platelet interaction using monoclonal antibodies. Blood 1985; 66: 1292-1301
  • 26 Hamamoto K, Nomura S, Suzuki M, Ohga S, Fukuhara S. Internalization of anti-glycoprotein IIb/IIIa antibody by HEL cells. Thromb Haemost 1995; 73: 291-296
  • 27 Nomura S, Nagata H, Oda K, Kokawa T. Effects of EDTA on the membrane glycoprotein Hb-HIa complex analysis using flow cytometry. Thromb Res 1987; 47: 47-58
  • 28 Suzuki M, Kawakatsu T, Nagata H, Hamamoto K, Iwata K, Ohga S, Nomura S, Kokawa T, Yasunaga K. Effects of injected antibody against the platelet glycoprotein Ilb/IIIa complex on monkey platelet fibrinogen. Thromb Haemost 1992; 67: 578-581
  • 29 Wicki AN, Clemetson JM, Steiner B, Schnippering W, Clemetson KJ. Isolation and characterization of glycoprotein lb. Methods in Enzymology 1992; 215: 276-288
  • 30 Laemmli UK. Cleavage of structual proteins during assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
  • 31 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976; 72: 248-254
  • 32 Tarentino AL, Gomez CM, Plummer Jr TH. Deglycosylation of asparagine-linked glycans by peptide: N-glycosidase F. Biochemistry 1985; 24: 4665-4671
  • 33 Geysen HM, Meloen RH, Barteling SJ. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci USA 1984; 81: 3998-4002
  • 34 Merrifield RB. Solid-phase peptide synthesis: the synthesis of a tetra- peptide. J Amer Chem Soc 1963; 85: 2149-2154
  • 35 Houmard J, Drapeau GR. Staphylococcal protease: A proteolytic enzyme specific for glutamoyl bonds. Proc Natl Acad Sci USA 1972; 69: 3506-3509
  • 36 Schagger H, Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987; 166: 368-379
  • 37 Hickey MJ, Deaven LL, Roth GJ. Human platelet glycoprotein IX: Characterization of cDNA and localization of the gene to chromosome 3. FEBS Lett 1990; 274: 189-192
  • 38 Li CQ, Dong JF, Lanza F, Sanan DA, Sae-Tung G, Lopez JA. Expression of platelet glycoprotein (GP) V in heterologous cells and evidence for its association with GP lb alpha in forming a GP Ib-IX-V complex on the cell surface. J Biol Chem 1995; 270: 16302-16307
  • 39 Lopez JA, Li CQ, Weisman S, Chambers M. The glycoprotein Ib-IX complex-specific monoclonal antibody SZ1 binds to a conformation- sensitive epitope on glycoprotein IX: implications for the target antigen of quinine/quinidine-dependent autoantibodies. Blood 1995; 85: 1245-1248
  • 40 Lopez JA, Weisman S, Sih T, Li CQ, Sanan DA. Association of GP lb with actin-binding protein does not require GP IX. Blood Coagul Fibrinolysis 1994; 05: 479-486
  • 41 Roth GJ, Ozols J, Nugent DJ, Williams SA. Isolation and characterization of human platelet glycoprotein IX. Biochem Biophys Res Commun 1988; 156: 931-939